Search Within

Chung-Han Lee

Formats
  1. Meeting Abstract (79)
  2. Journal Article (63)
  3. Review (9)
  4. Research Letter (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (157)
  2. Genitourinary Oncology Service (157)
  3. Solid Tumor Oncology Division (157)
  4. Weinberg Fellows (85)
  5. Department of Pathology and Laboratory Medicine (59)
  6. Population Sciences Research Program (59)

More Groups

People
  1. Robert Motzer (109)
  2. Martin Voss (75)
  3. Darren Feldman (55)
  4. Maria Carlo (55)
  5. Abraham Hakimi (42)
  6. Ritesh Kotecha (42)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (19)
  4. 2022 (23)
  5. 2021 (20)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (63)
  2. Annals of Oncology (9)
  3. Clinical Cancer Research (6)
  4. Clinical Genitourinary Cancer (6)
  5. European Urology (5)
  6. European Urology Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. Oxford University Press (13)
  3. Elsevier Inc. (11)
  4. Nature Publishing Group (11)
  5. American Association for Cancer Research (9)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (157)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Personalizing first-line management of metastatic renal cell carcinoma: Leveraging current and novel therapeutic options
    Review

    Fitzgerald, K. N.; Lee, C. H.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Identifying potential mechanisms of resistance to erdafitinib (erda) via longitudinal analysis of circulating tumor (ct)-DNA of patients (pts) with advanced/metastatic urothelial cancer
    Meeting Abstract

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Chen, Z.; Lattanzi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas
    Journal Article

    Yoo, A.; Tang, C.; Zucker, M.; Fitzgerald, K.; DiNatale, R. G.; Rappold, P. M.; Weiss, K.; Freeman, B.; Lee, C. H.; Schultz, N.; more...
    European Urology Focus (2022)

    Fulltext@MSK | Save
  • Phase II KEYNOTE-B61 study of pembrolizumab (Pembro) + lenvatinib (Lenva) as first-line treatment for non-clear cell renal cell carcinoma (nccRCC)
    Meeting Abstract

    Albiges, L.; Gurney, H. P.; Atduev, V.; Suarez, C.; Duran, M. A. C.; Pook, D.; Tomczak, P.; Barthelemy, P.; Lee, J. L.; Nalbandian, T.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Leveraging big data of immune checkpoint blockade response identifies novel potential targets
    Review

    Bareche, Y.; Kelly, D.; Abbas-Aghababazadeh, F.; Nakano, M.; Esfahani, P. N.; Tkachuk, D.; Mohammad, H.; Samstein, R.; Lee, C. H.; Morris, L. G. T.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade
    Journal Article

    Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of adrenal insufficiency (AI) due to anti-PD(L)-1 immune checkpoint inhibitors (ICI) among patients with cancer
    Meeting Abstract

    Nguyen, B.; Shah, N. J.; Knezevic, A.; Newman, S.; Fitzgerald, K. N.; Kotecha, R.; Lee, C. H.; Carlo, M. I.; Aggen, D. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save